DG(14:0/22:4(7Z,10Z,13Z,16Z)/0:0)

RJWUOCNQTGXKIH-QILILDRISA-N CHEBI:88790 0 Reactome links 3 studies

3 Observed studies

5 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: RJWUOCNQTGXKIH-QILILDRISA-N
InChI Key: RJWUOCNQTGXKIH-QILILDRISA-N
IUPAC name
Preferred name: DG(14:0/22:4(7Z,10Z,13Z,16Z)/0:0)
INN name: —
Synonym: DG(36:4)
ChEBI: CHEBI:88790

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)

Observed in differential profiles